Csenge Advisory Group’s Allergan plc AGN Stock Holding History

Csenge Advisory Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,450	Closed	-$257K	–	426
2020 Q1	$257K	Buy	1,450 +219	+18%	+$41.2K	0.07%	239
2019 Q4	$235K	Sell	1,231 -235	-16%	-$42.4K	0.06%	251
2019 Q3	$247K	Sell	1,466 -6	-0.4%	-$978	0.07%	227
2019 Q2	$246K	Sell	1,472 -115	-7%	-$15.9K	0.08%	165
2019 Q1	$232K	Buy	+1,587	New	+$230K	0.08%	175
2018 Q4	–	Sell	-2,319	Closed	-$365K	–	1747
2018 Q3	$365K	Buy	2,319 +73	+3%	+$13.4K	0.14%	99
2018 Q2	$374K	Buy	+2,246	New	+$361K	0.14%	151

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Csenge Advisory Group's AGN Position: Q2 2020 in Review

Csenge Advisory Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,450 shares — an estimated $257K sold.

Csenge Advisory Group first reported a position in AGN in Q2 2018 and held it in 7 quarters. The position peaked at $374K in Q2 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Csenge Advisory Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Csenge Advisory Group sold 1,450 Allergan plc shares in Q2 2020, an estimated $257K.
Csenge Advisory Group first reported a position in Allergan plc in Q2 2018 and held it in 7 quarters.
Csenge Advisory Group's Allergan plc position peaked at $374K in Q2 2018.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Csenge Advisory Group's 13F filing for Q2 2020, filed 17 Jul 2020.